Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,425
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Tampa FL, Chapel Hill NC, Lexington KY, Morgantown WV,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohn Disease
Location: Tampa FL, Clearwater FL, Brandon FL, Temple Terrace FL,
Sponsor: Abivax S.A.
Sex: All
Age: 18 - 70+
Code: NCT06456593
Phase 2, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Tampa FL, Lady Lake FL, Ocala FL, Boynton Beach FL,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase 1, Phase 2, Recruiting
Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma
for
Advanced Basal Cell Carcinoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05651828
Early Phase 1, Recruiting
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
Get alerts for new trials in your area by subscribing now
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
for
Peritoneal Carcinomatosis, Ovarian Cancer
Location: Tampa FL
Sponsor: Oncoinvent Solutions AS
Sex: Female
Age: 18+
Code: NCT06504147
Phase 2, Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Tampa FL, Orlando FL, Atlanta GA, Charlotte NC,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: Tampa FL, Nashville TN, Denver CO, Houston TX,
Sponsor: Nested Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06326411
Phase 1, Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Orlando FL, Jacksonville FL, Augusta GA, Atlanta GA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Tampa FL, Cincinnati OH, San Antonio TX,
Sponsor: Hanmi Pharmaceutical Company Limited
Sex: All
Age: 18+
Code: NCT06234397
Phase 1, Recruiting
Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma
for
High Grade Sarcoma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05301283
Phase 2, Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
for
Abdominal Aortic Aneurysm,
Location: Sarasota FL, Jacksonville FL, Atlanta GA,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 20+
Code: NCT05378347
Recruiting
Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma
for
Myeloma
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT06947083
Phase 2, Recruiting
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS
for
AML, Adult, MDS
Location: Tampa FL, Houston TX, Columbus OH, St Louis MO,
Sponsor: Stelexis BioSciences
Sex: All
Age: 18+
Code: NCT06533761
Phase 1, Recruiting
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
for
Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04741997
Early Phase 1, Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
for
Multiple Myeloma
Location: Tampa FL, Orlando FL, Charleston SC, Atlanta GA,
Sponsor: European Myeloma Network B.V.
Sex: All
Age: 18+
Code: NCT05243797
Phase 3, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Tampa FL, Clermont FL, Fort Lauderdale FL, Daphne AL,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
for
Primary Myelofibrosis
Location: Tampa FL, Charlotte NC, Houston TX, Cincinnati OH,
Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06343805
Phase 1, Recruiting
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
for
Gastroparesis, Gastroparesis Nondiabetic,
Location: Tampa FL, Louisville KY, Saint Louis MO, Detroit MI,
Sponsor: Enterra Medical, Inc.
Sex: All
Age: 18 - 70
Code: NCT06560307
Recruiting
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
for
Keratitis, Corneal Ulcer
Location: Tampa FL, Fort Myers FL, Columbia SC, Chattanooga TN,